Dissecting rare gliomas

Harvard, Mass General researchers ID cells, targets driving rare pediatric glioma

In an April Science study, researchers from Massachusetts General Hospital and Harvard Medical School identified a subpopulation of malignant cells driving disease progression in rare pediatric gliomas with mutated histone H3 K27M using single-cell RNA sequencing analysis, thereby revealing novel pathways that could be targeted to treat the disease.

Read the full 498 word article

User Sign In